ArticleBioinformation2026
TGL / HDL - C ratio and non-HDL-C - prognostic index in chronic kidney disease.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dyslipidemia, a major risk factor for chronic kidney disease (CKD) affects more than ten percent of the general population. Dyslipidemia in CKD, if left untreated, will result in end stage renal disease. So, the relationship between atherogenic lipid profile ratios and the assessment of CKD severity is a potential area still to be explored. In assessing the severity of CKD, these ratios have higher prognostic value than individual parameters alone. Therefore, it is of interest to evaluate the role of TGL/HDL- c ratio and NON- HDL-c levels in assessing the disease severity in CKD. Cross-sectional study with one hundred and thirteen CKD patients divided into two groups based-on e-GFR levels and CKD-EPIDEMIOLOGY Staging. Quantitative measurements of lipid profile parameters (total cholesterol, triglycerides, HDL-c) done by enzymatic colorimetric method and renal function test by spectrophotometric method. TGL: HDL-c and NON- HDL-c levels were calculated, Statistical data analyzed using SPSS version software 16.0 showed TGL / HDL- c ratio and NON-HDL-c values has significant correlation with CKD staging and found to highly significant (p <0.001). TGL / HDL-c ratio and NON-HDL-c value can be used as a prognostic index in CKD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.